Literature DB >> 6252433

Clostridium botulinum neurotoxin.

H Sugiyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252433      PMCID: PMC373187          DOI: 10.1128/mr.44.3.419-448.1980

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


× No keyword cloud information.
  195 in total

1.  Toxicity enhancement of Clostridium botulinum type A and B culture filtrates by proteolytic enzymes.

Authors:  P F BONVENTRE; L L KEMPE
Journal:  J Bacteriol       Date:  1959-12       Impact factor: 3.490

2.  Gangliosides in nervous tissue cultures and binding of 125I-labelled tetanus toxin, a neuronal marker.

Authors:  W Dimpfel; R T Huang; E Habermann
Journal:  J Neurochem       Date:  1977-08       Impact factor: 5.372

3.  Binding of ganglioside by the chains of tetanus toxin.

Authors:  S van Heyningen
Journal:  FEBS Lett       Date:  1976-09-15       Impact factor: 4.124

4.  Inhibition by botulinum toxin of depolarization-evoked release of (14C)acetylcholine from synaptosomes in vitro.

Authors:  S Wonnacott; R M Marchbanks
Journal:  Biochem J       Date:  1976-06-15       Impact factor: 3.857

5.  Bacteriophages of Clostridium botulinum.

Authors:  C E Dolman; E Chang
Journal:  Can J Microbiol       Date:  1972-01       Impact factor: 2.419

6.  The effects of acute and chronic botulinum toxin treatment on receptor number, receptor distribution and tissue sensitivity in rat diaphragm.

Authors:  L L Simpson
Journal:  J Pharmacol Exp Ther       Date:  1977-02       Impact factor: 4.030

7.  Studies on strain 84 of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

8.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.

Authors:  H M Solomon; R K Lynt; D A Kautter; T Lilly
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

10.  Penicillin-Lysozyme Conversion of Clostridium botulinum Types A and E into Protoplasts and Their Stabilization as L-Form Cultures.

Authors:  G W Brown; G King; H Sugiyama
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490

View more
  75 in total

1.  Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.

Authors:  S Kozaki; A Miki; Y Kamata; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.

Authors:  Toshio Nakamura; Takashi Tonozuka; Mao Kotani; Kanae Obata; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

4.  Botulism with sensory symptoms: a second case.

Authors:  J C Martínez-Castrillo; M A Del Real; A Hernandez Gonzalez; G De Blas; J C Alvarez-Cermeño
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

5.  Wound botulism from heroin skin popping.

Authors:  Larry E Davis; Molly K King
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 6.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.

Authors:  S Kozaki; Y Kamata; T Nagai; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

8.  Botulism in metronidazole- treated conventional adult mice challenged orogastrically with spores of Clostridium botulinum type A or B.

Authors:  Y Wang; H Sugiyama
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.

Authors:  M Dezfulian; J G Bartlett
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

10.  Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.

Authors:  Paul T Bremer; Michael Adler; Cecilia H Phung; Ajay K Singh; Kim D Janda
Journal:  J Med Chem       Date:  2017-01-03       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.